Carl Zeiss Meditec AG (LTS:0DHC)

Q1 2025 Carl Zeiss Meditec AG Earnings Call Transcript

Feb 12, 2025 / 09:00 AM GMT

Release Date Price: €51.23 (-12.20%)

Transcript

Key Points

Positve

Carl Zeiss Meditec AG (CZMWF) reported a 3.2% increase in revenue for Q1 2025 compared to the same period last year.
The company saw a significant recovery in order entry, reaching €522 million, a 34.4% increase at constant currency.
The approval of the Visa Max 800 in China was achieved earlier than expected, potentially boosting future sales.
Recurring revenue now accounts for 47.3% of total revenue, indicating a stable income stream.
The company has implemented strict cost control measures, leading to a reduction in R&D expenses and underlying operating expenses.

Negative

When adjusted for FX and acquisitions, revenue actually declined by 7.3% due to strong prior year comparisons and a weaker investment climate, particularly in China.
EBITA declined by 23.5% compared to the prior year, resulting in a margin drop from 9.7% to 7.2%.
The gross margin decreased to 51.4% due to an unfavorable product mix and price cuts in IOLs.
Net income dropped significantly from €37 million to €160 million, with earnings per share declining by 57.1%.
The company faces ongoing challenges in China, with a decline in sales due to product cycle transitions and restrictive investment climates.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AFXG.DE - Carl Zeiss Meditec AG
Q1 2025 Carl Zeiss Meditec AG Earnings Call
Feb 12, 2025 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen. Thanks for joining our 3 month 24, 25 endless conference call. My name is Sebastian. I'm the head of investor relations, and I'm here with our President and CEO, Dr. Marcus Weber, and our CFO Jous Weber, who will present, the 3 month results, guide you for financials and outlook and discuss some highlights. Afterwards, we look forward to your questions. I'd like to hand over to Marcus now.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, thank you so much, Sebastian and also a very warm welcome and good morning ladies and gentlemen

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.